Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-17

FDA Approved: FLURAZEPAM HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for flurazepam hydrochloride, with Chartwell RX, LLC listed as the manufacturer. Flurazepam hydrochloride is a benzodiaz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flurazepam hydrochloride (Flurazepam hydrochloride)

Snippet

SUPPL AP for FLURAZEPAM HYDROCHLORIDE (FLURAZEPAM HYDROCHLORIDE)